Examining the State of Drug Importation and Drug Pricing

Chair of the firm’s Intellectual Property and Food and Drug Regulatory practices Eileen McMahon will speak on Examining the State of Drug Importation and Drug Pricing webinar hosted by Food and Drug Law Institute (FDLI) on February 11.

Eileen, along with other panelists, will address the state of drug importation during COVID-19, and possible effect to the U.S. drug market. The session will also discuss an in-depth review of both actions, focusing on the Safe Importation Action Plan and how Canadian regulators and manufacturers have responded, the risks of foreign unapproved drugs, and more.

You can register for this webinar on FDLI’s website.